Researcher looks at liver disease

June 2011
Edge (East Carolina University);Summer2011, p2
The article focuses on a study conducted by Doctor Ian Hines, an assistant professor of nutrition science, on the effect of T lymphocytes on processes that cause the transition from mild liver injury to fibrosis and cirrhosis. It says that the aim is to define new targets for effectively predicting, treating or preventing the progression of liver disease. It adds that Hines is working through the help of a 100,000 U.S.-dollar grant from the U.S. Alcoholic Beverage Medical Research Foundation.


Related Articles

  • Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation. Ya-Wei Liu; Yung-Tsung Chiu; Shu-Ling Fu; Yi-Tsau Huang // Journal of Biomedical Science;Aug2015, Vol. 22 Issue 1, p1 

    Background: Hepatic fibrosis is a dynamic process which ultimately leads to cirrhosis in almost patients with chronic hepatic injury. However, progressive fibrosis is a reversible scarring response. Activation of hepatic stellate cells (HSCs) is the prevailing process during hepatic fibrosis....

  • The Nrf2 transcription factor protects from toxin-induced liver injury and fibrosis. Weihua Xu; Hellerbrand, Claus; Köhler, Ulrike A.; Bugnon, Philippe; Yuet-Wai Kan; Werner, Sabine; Beyer, Tobias A. // Laboratory Investigation (00236837);Oct2008, Vol. 88 Issue 10, p1068 

    The liver is frequently exposed to insults, including toxic chemicals and alcohol, viral infection or metabolic overload. Although it can fully regenerate after acute injury, chronic liver damage causes liver fibrosis and cirrhosis, which can result in complete liver failure. In this study, we...

  • Effectiveness of the PPARγ agonist, GW570, in liver fibrosis. Yang, Liu; Stimpson, Stephen; Chen, Lihong; Wallace Harrington, W.; Rockey, Don // Inflammation Research;Dec2010, Vol. 59 Issue 12, p1061 

    Introduction: The peroxisome proliferator-activated receptors (PPARs) are well established to be important in modulating the fibrogenic response to liver injury. PPARγ plays a role in hepatic fibrosis, presumably by virtue of its expression in hepatic stellate cells, which are key effectors...

  • Sex-oriented diagnosis and therapy of hepatitis C. Villa, Erica // Hot Topics in Viral Hepatitis;2013, Vol. 9 Issue 27, p13 

    Chronic liver disease progresses at unequal rates in the 2 sexes both in viral hepatitis and in liver injury of different etiology. Fibrosis and/or cirrhosis develop earlier and are more severe in men than they are in women. Estrogens are supposed to have a protective role in preventing...

  • The Synthetic Triterpenoid RTA 405 (CDDO-EA) Halts Progression of Liver Fibrosis and Reduces Hepatocellular Carcinoma Size Resulting in Increased Survival in an Experimental Model of Chronic Liver Injury. Getachew, Yonas; Cusimano, Frank A.; Gopal, Purva; Reisman, Scott A.; Shay, Jerry W. // Toxicological Sciences;Jan2016, Vol. 149 Issue 1, p111 

    Patients with cirrhosis have an increased risk of developing liver cancer and a higher rate of mortality. Cirrhosis currently has no known cure, and patients may benefit from new agents aimed at alleviating their complications and slowing down the rate of disease progression. Therefore, the...

  • Systems Level Analysis and Identification of Pathways and Networks Associated with Liver Fibrosis. AbdulHameed, Mohamed Diwan M.; Tawa, Gregory J.; Kumar, Kamal; Ippolito, Danielle L.; Lewis, John A.; Stallings, Jonathan D.; Wallqvist, Anders // PLoS ONE;Nov2014, Vol. 9 Issue 11, p1 

    Toxic liver injury causes necrosis and fibrosis, which may lead to cirrhosis and liver failure. Despite recent progress in understanding the mechanism of liver fibrosis, our knowledge of the molecular-level details of this disease is still incomplete. The elucidation of networks and pathways...

  • TRAIL-producing NK cells contribute to liver injury and related fibrogenesis in the context of GNMT deficiency. Fernández-Álvarez, Sara; Gutiérrez-de Juan, Virginia; Zubiete-Franco, Imanol; Barbier-Torres, Lucia; Lahoz, Agustín; Parés, Albert; Luka, Zigmund; Wagner, Conrad; Lu, Shelly C; Mato, José M; Martínez-Chantar, María L; Beraza, Naiara // Laboratory Investigation (00236837);Feb2015, Vol. 95 Issue 2, p223 

    Glycine-N-methyltransferase (GNMT) is essential to preserve liver homeostasis. Cirrhotic patients show low expression of GNMT that is absent in hepatocellular carcinoma (HCC) samples. Accordingly, GNMT deficiency in mice leads to steatohepatitis, fibrosis, cirrhosis, and HCC. Lack of GNMT...

  • Hepatocyte Produced Matrix Metalloproteinases Are Regulated by CD147 in Liver Fibrogenesis. Calabro, Sarah R.; Maczurek, Annette E.; Morgan, Alison J.; Tu, Thomas; Wen, Victoria W.; Yee, Christine; Mridha, Auvro; Lee, Maggie; d'Avigdor, William; Locarnini, Stephen A.; McCaughan, Geoffrey W.; Warner, Fiona J.; McLennan, Susan V.; Shackel, Nicholas A. // PLoS ONE;Jul2014, Vol. 9 Issue 7, p1 

    Background: The classical paradigm of liver injury asserts that hepatic stellate cells (HSC) produce, remodel and turnover the abnormal extracellular matrix (ECM) of fibrosis via matrix metalloproteinases (MMPs). In extrahepatic tissues MMP production is regulated by a number of mechanisms...

  • Cytokines in alcoholic liver disease. An, Leon; Wang, Xiaodong; Cederbaum, Arthur // Archives of Toxicology;Sep2012, Vol. 86 Issue 9, p1337 

    Alcoholic liver disease (ALD) is associated with a spectrum of liver injury ranging from steatosis and steatohepatitis to fibrosis and cirrhosis. While multifactorial pathogenesis plays a role in the disease progression, enhanced inflammation in the liver during ethanol exposure is a major...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics